European Archives - Page 1166 of 1191 - European Medical Journal

Current Developments and Perspectives in Multiple Myeloma

In the last decades, advances in the therapeutic management of multiple myeloma (MM) with new drug armamentarium and strategies have significantly…

Autologous Stem Cell Transplantation In Multiple Myeloma: Is It Still The Right Choice?

Autologous stem cell transplantation (ASCT) is considered the standard of care for multiple myeloma patients aged <65 years with no relevant…

The Role of JAK2 Mutation in Thrombotic Complications of Chronic Myeloproliferative Neoplasms

Patients diagnosed with myeloproliferative neoplasms (MPNs) often develop thrombotic events as an onset of symptoms or in evolution. The pathogenesis of…

Calreticulin in Myeloproliferative Neoplasms: The Other Side of the Alice Mirror

Calreticulin (CALR), a Ca2+ binding protein mostly localised in the endoplasmic reticulum, regulates Ca2+ homeostasis, chaperones, and other proteins to…

Iron Supplementation for Perioperative Anaemia in Patient Blood Management

In patients undergoing major surgical procedures, preoperative anaemia and perioperative allogeneic blood transfusion (ABT) have been linked to increased…

Looking Back To Our Roots: 80 Years of Wintrobe’s Indices

This year (2014) we are celebrating the 80th anniversary of Dr Maxwell Myer Wintrobe’s pioneer works, one of the most important contributions in clinical…

EMJ Hematology 2.1 2014

Welcome to the European Medical Journal – Hematology 2014 edition.

EMJ

What’s Wrong with Modern Medicine?

Despite not knowing much about biology, and being able to successfully treat very few diseases, doctors in the 19th century were held in very high regard.

EMJ

Blood Test for Cancer Shows Promise

A universal blood test to detect cancer developed by scientists at the UK’s University of Bradford is showing promise in trials, raising hopes for…

EMJ

New Treatment Option for CLL Patients with Poorest Prognosis

Patients with a particularly difficult-to-treat form of chronic lymphocytic leukaemia have gained access to a new treatment option in the US…